ライフサイエンスコーパス: nontuberculous mycobacteria

1 osa, Haemophilus, Aspergillus fumigatus, and nontuberculous mycobacteria.

2 osed glycolipids present in a broad range of nontuberculous mycobacteria.

3 ons with intracellular pathogens, especially nontuberculous mycobacteria.

4 MGIT cultures included both tuberculous and nontuberculous mycobacteria.

5 evalence population, including the impact of nontuberculous mycobacteria.

6 concern about public health issues regarding nontuberculous mycobacteria.

7 dentification of MTC and clinically relevant nontuberculous mycobacteria.

8 isseminated infections with environmental or nontuberculous mycobacteria.

9 greater percentage had cultures positive for nontuberculous mycobacteria.

10 with DNA from Mycobacterium avium and other nontuberculous mycobacteria.

11 the culture filtrates of M. avium and other nontuberculous mycobacteria.

12 16 were MTBC (from 12 patients), and 41 were nontuberculous mycobacteria.

13 CG or from sensitization with environmental, nontuberculous mycobacteria.

14 imens of M. tuberculosis and 29 specimens of nontuberculous mycobacteria.

15 that this array can identify the species of nontuberculous Mycobacteria.

16 nfer susceptibility to severe infection with nontuberculous mycobacteria.

17 f in vitro biofilms of fast and slow-growing nontuberculous mycobacteria.

18 e 1,353 isolates recovered, 1,110 (82%) were nontuberculous mycobacteria, 145 (11%) were aerobic acti

19 after 6 weeks of incubation included 65 (5%) nontuberculous mycobacteria, 4 (0.3%) aerobic actinomyce

20 onella and other gram-negative bacteria, and nontuberculous mycobacteria, although fungi and viruses

21 s assessed by DNA extraction from species of nontuberculous mycobacteria and amplification using the

22 test reactions associated with reactivity to nontuberculous mycobacteria and bacille Calmette-Guerin

23 All 98 cultures with nontuberculous mycobacteria and the 107 that did not con

24 acterium tuberculosis complex (MTBC), 6 grew nontuberculous mycobacteria, and 2 (from two patients di

25 vaccination, discriminated responses due to nontuberculous mycobacteria, and avoided variability and

26 A extracted from Mycobacterium tuberculosis, nontuberculous mycobacteria, and nonmycobacterial specie

27 (IFN)-gamma autoantibodies and disseminated nontuberculous mycobacteria; anti-granulocyte macrophage

28 The nontuberculous mycobacteria are a large group of acid-fa

29 Nontuberculous mycobacteria are emerging pathogens, yet

30 Nontuberculous mycobacteria are environmental organisms

31 nosa, Vibrio cholerae and certain species of nontuberculous mycobacteria are examples of human pathog

32 Nontuberculous mycobacteria are increasingly encountered

33 Nontuberculous mycobacteria are ubiquitous in the enviro

34 abscessus, a species of multidrug-resistant nontuberculous mycobacteria, are emerging as an importan

35 secutive patients with positive cultures for nontuberculous mycobacteria between 2005 and 2016.

36 Nontuberculous mycobacteria can form true cords in broth

37 m abscessus complex (MABC), an opportunistic nontuberculous mycobacteria, can lead to poor clinical o

38 Recovery of the tuberculous and nontuberculous mycobacteria following CB-18 processing a

39 false positive MTD results in patients with nontuberculous mycobacteria, for a specificity in this p

40 al nervous system (CNS) infections caused by nontuberculous mycobacteria have been described previous

41 Infections caused by nontuberculous mycobacteria have increased more than 50%

42 as capable of identifying several species of nontuberculous mycobacteria in addition to identifying M

43 ium avium complex (83%) were the most common nontuberculous mycobacteria in Thailand and the United S

44 omplex (83%) were the most commonly isolated nontuberculous mycobacteria in Thailand and the US, resp

45 Nonsequencing methods for identification of nontuberculous mycobacteria (including those of the MAC)

46 pidemiology and management of extrapulmonary nontuberculous mycobacteria infections in orthotopic hea

47 Colonization of the airways by nontuberculous mycobacteria is a harbinger of invasive l

48 ere the environmental burden of saprophytic, nontuberculous mycobacteria is high.

49 eficiency were independently associated with nontuberculous mycobacteria isolation.

50 oid Pseudomonas aeruginosa (n = 12; 15%) and nontuberculous mycobacteria (n = 8; 10%) were present in

51 onale: Healthcare-associated transmission of nontuberculous mycobacteria (NTM) among people with cyst

52 Nontuberculous mycobacteria (NTM) and Legionella pneumop

53 as developed for efficient identification of nontuberculous mycobacteria (NTM) and their environmenta

54 Nontuberculous mycobacteria (NTM) are a rare cause of in

55 Nontuberculous mycobacteria (NTM) are an important cause

56 Nontuberculous mycobacteria (NTM) are emerging human pat

57 Nontuberculous mycobacteria (NTM) are frequently found i

58 Nontuberculous Mycobacteria (NTM) are opportunistic path

59 Nontuberculous mycobacteria (NTM) are opportunistically

60 Nontuberculous mycobacteria (NTM) are potential respirat

61 Rationale: Nontuberculous mycobacteria (NTM) are prevalent among pa

62 ogy of healthcare facility-associated (HCFA) nontuberculous mycobacteria (NTM) are sparse.

63 Nontuberculous mycobacteria (NTM) are ubiquitous in the

64 Nontuberculous mycobacteria (NTM) are ubiquitous in the

65 Although nontuberculous mycobacteria (NTM) are widely documented

66 ine is essential for viability and growth of nontuberculous mycobacteria (NTM) by providing the biolo

67 Nontuberculous mycobacteria (NTM) cause pulmonary (PNTM)

68 Nontuberculous mycobacteria (NTM) cause pulmonary and ex

69 Nontuberculous mycobacteria (NTM) commonly colonize muni

70 idrug-resistant strains, and some species of nontuberculous mycobacteria (NTM) compared with that of

71 Studies of nontuberculous mycobacteria (NTM) described a rapid rise

72 ex (MTBC) and 1.00, 0.97, 0.75, and 1.00 for nontuberculous mycobacteria (NTM) detection, respectivel

73 he increasing global prevalence of pulmonary nontuberculous mycobacteria (NTM) disease has called att

74 The global incidence of the human nontuberculous mycobacteria (NTM) disease is rapidly inc

75 opriate antimicrobial treatment regimens for nontuberculous mycobacteria (NTM) disease.

76 uginosa and allow the successful recovery of nontuberculous mycobacteria (NTM) from cystic fibrosis (

77 us (AFB) culture method for the isolation of nontuberculous mycobacteria (NTM) from patients with CF.

78 Isolation of nontuberculous mycobacteria (NTM) from the sputum of pat

79 ility of MALDI-TOF for the identification of nontuberculous mycobacteria (NTM) has improved recently

80 Worldwide, nontuberculous mycobacteria (NTM) have become emergent p

81 outbreaks and pseudo-outbreaks caused by the nontuberculous mycobacteria (NTM) have been recognized f

82 Nontuberculous mycobacteria (NTM) infect children with i

83 Nontuberculous mycobacteria (NTM) infection has attracte

84 Risk factors for nontuberculous mycobacteria (NTM) infections after solid

85 and the specificity of QFT in patients with nontuberculous mycobacteria (NTM) infections is incomple

86 The prevalence of nontuberculous mycobacteria (NTM) is high (approximately

87 Pulmonary disease (PD) due to nontuberculous mycobacteria (NTM) is increasing globally

88 Infection with nontuberculous mycobacteria (NTM) is of growing clinical

89 entiation of Mycobacterium tuberculosis from nontuberculous mycobacteria (NTM) is of primary importan

90 The nontuberculous mycobacteria (NTM) Mycobacterium avium is

91 erium abscessus complex (MABSC) is a form of Nontuberculous mycobacteria (NTM) of special, internatio

92 Nontuberculous mycobacteria (NTM) represent over 190 spe

93 ed on its ability to accurately identify 314 nontuberculous mycobacteria (NTM) representing 73 specie

94 The prevalence of nontuberculous mycobacteria (NTM) showed a decreasing tr

95 cation of MTBC and differential diagnosis of nontuberculous mycobacteria (NTM) species impose challen

96 rium tuberculosis complex (MTC) strains from nontuberculous Mycobacteria (NTM) strains by targeting t

97 /43 (100%), 57/76 (75%) of the rapid growing nontuberculous mycobacteria (NTM), and 42/48 (85%) slow

98 detected by either method; Legionella spp., nontuberculous mycobacteria (NTM), and Mycobacterium avi

99 and difficult-to-cure lung disease caused by nontuberculous mycobacteria (NTM), for which the drug de

100 dence of pulmonary infection via aerosolized nontuberculous mycobacteria (NTM), it is important to ch

101 s, as well as environmental species known as nontuberculous mycobacteria (NTM), some of which-namely

102 rved that this peptide was effective against nontuberculous mycobacteria (NTM), such as M. avium and

103 d preparations of different immunoregulatory nontuberculous mycobacteria (NTM), such as M. vaccae NCT

104 Mycobacterium tuberculosis complex (MTC) and nontuberculous mycobacteria (NTM), using surface-enhance

105 bacterium haemophilum is a rare and emerging nontuberculous mycobacteria (NTM).

106 a mainstay of therapy for infections due to nontuberculous mycobacteria (NTM).

107 ion, likely driven by a 2 log 10 increase in nontuberculous mycobacteria (NTM).

108 ddlebrook 7H11 agar for the isolation of all nontuberculous mycobacteria (NTM).

109 detection of Mycobacterium tuberculosis and nontuberculous mycobacteria (NTM).

110 opes unique in LAM from MTB and slow-growing nontuberculous mycobacteria (NTM).

111 had antemortem sputum cultures positive for nontuberculous mycobacteria (NTM).

112 e for treating bacterial pathogens including nontuberculous mycobacteria (NTM).

113 Nontuberculous mycobacteria (NTMs) are environmental mic

114 ern corresponded to sequence conservation in nontuberculous mycobacteria (NTMs), suggesting environme

115 e-positive by Xpert MTB/RIF in patients with nontuberculous mycobacteria, old PTB scar, and immune re

116 ociated with prior pneumonia, infection with nontuberculous mycobacteria or tuberculosis, genetic con

117 Pulmonary nontuberculous mycobacteria (PNTM) are an important caus

118 features of patients infected with pulmonary nontuberculous mycobacteria (PNTM) are well described, b

119 Nontuberculous mycobacteria reportability and surveillan

120 Mycobacterium kansasii is a slow-growing nontuberculous mycobacteria responsible for coinfections

121 Symptomatic patients with pulmonary nontuberculous mycobacteria should be presumptively trea

122 ls have more cases of clinically significant nontuberculous mycobacteria than tuberculosis, the manag

123 complex (MAC) is a group of closely related nontuberculous mycobacteria that can cause various disea

124 lderia, Stenotrophomonas, Achromobacter, and nontuberculous mycobacteria that drive cycles of infecti

125 pidly growing species of multidrug-resistant nontuberculous mycobacteria that has emerged as a growin

126 Nontuberculous mycobacteria were isolated in 46 children

127 Nontuberculous mycobacteria were recovered from 12 (92%)